For the twelve months ended Sep 30, 2026, Bausch + Lomb Corporation reported $5.42B of revenue and -$111.00M of net income.
BLCO revenue was $1.38B in fiscal Q3 2026 (ended Sep 30, 2026), up 7.3% from a year earlier and down 1.4% from the prior quarter. For the full fiscal 2025 it was $5.10B, up 6.5% from fiscal 2024. Compound annual growth was +8.4% over 5 years. It rose in each of the last 5 fiscal years. Fiscal 2025 is the highest of the 6 fiscal years on file.
BLCO net income was $32.00M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$28.00M a year earlier. For the full fiscal 2025 it was -$360.00M, compared with -$317.00M in fiscal 2024.
BLCO diluted EPS was $0.09 in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$0.08 a year earlier. For the full fiscal 2025 it was -$1.02, compared with -$0.90 in fiscal 2024.
BLCO free cash flow was $178.00M in fiscal Q3 2026 (ended Sep 30, 2026), up 182.5% from a year earlier and up 117.1% from the prior quarter. For the full fiscal 2025 it was -$66.00M, compared with -$59.00M in fiscal 2024.
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Revenue | $5.10B | $4.79B | $4.15B | $3.77B | $3.77B | $3.41B |
| Research and development | $371.00M | $343.00M | $324.00M | $307.00M | $271.00M | $253.00M |
| Selling, general and admin | $2.23B | $2.08B | $1.74B | $1.48B | $1.39B | $1.25B |
| Operating income | $113.00M | $162.00M | $130.00M | $207.00M | $329.00M | $260.00M |
| Pre-tax income | -$317.00M | -$234.00M | -$166.00M | $73.00M | $318.00M | $290.00M |
| Income tax | $35.00M | $71.00M | $82.00M | $58.00M | $125.00M | $307.00M |
| Net income | -$360.00M | -$317.00M | -$260.00M | $6.00M | $182.00M | -$18.00M |
| EPS, basic | -$1.02 | -$0.90 | -$0.74 | $0.02 | $0.52 | -$0.05 |
| EPS, diluted | -$1.02 | -$0.90 | -$0.74 | $0.02 | $0.52 | -$0.05 |
| Diluted shares | 353.8M | 351.8M | 350.5M | 350.2M | 350.0M | 350.0M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | $383.00M | $316.00M | $334.00M | $380.00M | $177.00M | $238.00M |
| Receivables | $1.22B | $1.03B | $839.00M | $724.00M | $721.00M | - |
| Inventory | $976.00M | $1.04B | $1.03B | $628.00M | $572.00M | - |
| Current assets | $2.98B | $2.79B | $2.74B | $2.14B | $1.64B | - |
| Goodwill | $4.76B | $4.52B | $4.58B | $4.51B | $4.59B | $4.68B |
| Total assets | $14.02B | $13.47B | $13.44B | $11.14B | $10.82B | - |
| Current liabilities | $1.92B | $1.74B | $1.58B | $1.30B | $1.10B | - |
| Short-term debt | $28.00M | $40.00M | $30.00M | $25.00M | $0 | - |
| Long-term debt | $5.02B | $4.74B | $4.53B | $2.41B | $0 | - |
| Total debt | $5.05B | $4.78B | $4.56B | $2.44B | $0 | - |
| Total liabilities | $7.50B | $6.92B | $6.52B | $4.04B | $1.42B | - |
| Shareholders' equity | $6.45B | $6.54B | $6.92B | $7.10B | $9.40B | $9.99B |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $283.00M | $232.00M | -$17.00M | $345.00M | $873.00M | $522.00M |
| Capital expenditures | $349.00M | $291.00M | $181.00M | $175.00M | $193.00M | $253.00M |
| Free cash flow | -$66.00M | -$59.00M | -$198.00M | $170.00M | $680.00M | $269.00M |
| Investing cash flow | -$455.00M | -$412.00M | -$2.11B | -$215.00M | -$214.00M | -$256.00M |
| Financing cash flow | $225.00M | $178.00M | $2.08B | $81.00M | -$712.00M | -$232.00M |
| Stock-based compensation | $149.00M | $92.00M | $74.00M | $62.00M | $62.00M | $50.00M |
| Depreciation and amortization | $421.00M | $436.00M | $382.00M | $379.00M | $415.00M | $442.00M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Revenue growth, YoY | 6.5% | 15.6% | 10.0% | 0.1% | 10.3% | - |
| Net income growth, YoY | - | - | - | -96.7% | - | - |
| EPS growth, YoY | - | - | - | -96.2% | - | - |
| Operating margin | 2.2% | 3.4% | 3.1% | 5.5% | 8.7% | 7.6% |
| Net margin | -7.1% | -6.6% | -6.3% | 0.2% | 4.8% | -0.5% |
| Free cash flow margin | -1.3% | -1.2% | -4.8% | 4.5% | 18.1% | 7.9% |
| Return on equity | -5.6% | -4.8% | -3.8% | 0.1% | 1.9% | -0.2% |
| Return on assets | -2.6% | -2.4% | -1.9% | 0.1% | 1.7% | - |
| Current ratio | 1.55 | 1.60 | 1.74 | 1.65 | 1.49 | - |
| Debt to equity | 0.78 | 0.73 | 0.66 | 0.34 | 0.00 | - |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.38B | $1.39B | $1.24B | $1.41B | $1.28B | $1.28B | $1.14B | $1.28B | $1.20B | $1.22B | $1.10B | $1.17B |
| Research and development | $91.00M | $114.00M | $101.00M | $94.00M | $95.00M | $96.00M | $86.00M | $93.00M | $84.00M | $84.00M | $82.00M | $80.00M |
| Selling, general and admin | $556.00M | $588.00M | $544.00M | $564.00M | $528.00M | $579.00M | $563.00M | $532.00M | $511.00M | $535.00M | $504.00M | $483.00M |
| Operating income | $155.00M | $83.00M | $33.00M | $112.00M | $95.00M | -$11.00M | -$83.00M | $87.00M | $43.00M | $26.00M | $6.00M | $49.00M |
| Pre-tax income | $58.00M | -$11.00M | -$64.00M | $13.00M | -$3.00M | -$147.00M | -$180.00M | -$10.00M | -$58.00M | -$76.00M | -$90.00M | -$57.00M |
| Income tax | $23.00M | -$1.00M | $6.00M | $71.00M | $22.00M | -$89.00M | $31.00M | -$8.00M | -$66.00M | $72.00M | $73.00M | -$6.00M |
| Net income | $32.00M | -$14.00M | -$71.00M | -$58.00M | -$28.00M | -$62.00M | -$212.00M | -$3.00M | $4.00M | -$151.00M | -$167.00M | -$54.00M |
| EPS, basic | $0.09 | -$0.04 | -$0.20 | -$0.16 | -$0.08 | -$0.18 | -$0.60 | $0.00 | $0.01 | -$0.43 | -$0.48 | -$0.15 |
| EPS, diluted | $0.09 | -$0.04 | -$0.20 | -$0.16 | -$0.08 | -$0.18 | -$0.60 | $0.00 | $0.01 | -$0.43 | -$0.48 | -$0.15 |
| Diluted shares | 361.5M | 357.1M | 355.2M | - | 354.2M | 353.7M | 352.8M | - | 353.9M | 351.8M | 351.1M | - |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $513.00M | $367.00M | $268.00M | $383.00M | $332.00M | $272.00M | $215.00M | $316.00M | $350.00M | $302.00M | $325.00M | $334.00M |
| Receivables | $1.15B | $1.16B | $1.11B | $1.22B | $1.09B | $1.08B | $1.01B | $1.03B | $943.00M | $986.00M | $920.00M | $839.00M |
| Inventory | $1.01B | $999.00M | $977.00M | $976.00M | $1.00B | $1.05B | $1.03B | $1.04B | $1.12B | $1.07B | $1.07B | $1.03B |
| Current assets | $3.06B | $2.92B | $2.78B | $2.98B | $2.85B | $2.85B | $2.69B | $2.79B | $2.83B | $2.77B | $2.74B | $2.74B |
| Goodwill | $4.71B | $4.72B | $4.74B | $4.76B | $4.66B | $4.67B | $4.57B | $4.52B | $4.58B | $4.54B | $4.55B | $4.58B |
| Total assets | $13.96B | $13.86B | $13.78B | $14.02B | $13.83B | $13.83B | $13.43B | $13.47B | $13.52B | $13.25B | $13.29B | $13.44B |
| Current liabilities | $1.96B | $1.89B | $1.82B | $1.92B | $1.90B | $1.84B | $1.73B | $1.74B | $1.80B | $1.68B | $1.62B | $1.58B |
| Short-term debt | $28.00M | $28.00M | $28.00M | $28.00M | $28.00M | $28.00M | $40.00M | $40.00M | $30.00M | $30.00M | $30.00M | $30.00M |
| Long-term debt | $4.99B | $5.05B | $5.01B | $5.02B | $4.92B | $4.93B | $4.79B | $4.74B | $4.60B | $4.60B | $4.55B | $4.53B |
| Total debt | $5.02B | $5.08B | $5.04B | $5.05B | $4.95B | $4.96B | $4.83B | $4.78B | $4.63B | $4.63B | $4.58B | $4.56B |
| Total liabilities | $7.45B | $7.42B | $7.33B | $7.50B | $7.33B | $7.32B | $7.00B | $6.92B | $6.85B | $6.67B | $6.56B | $6.52B |
| Shareholders' equity | $6.44B | $6.44B | $6.45B | $6.45B | $6.50B | $6.51B | $6.43B | $6.54B | $6.66B | $6.58B | $6.73B | $6.92B |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $233.00M | $153.00M | $32.00M | $136.00M | $137.00M | $35.00M | -$25.00M | $22.00M | $154.00M | $15.00M | $41.00M | $15.00M |
| Capital expenditures | $55.00M | $71.00M | $100.00M | $76.00M | $74.00M | $89.00M | $110.00M | $92.00M | $60.00M | $72.00M | $67.00M | $84.00M |
| Free cash flow | $178.00M | $82.00M | -$68.00M | $60.00M | $63.00M | -$54.00M | -$135.00M | -$70.00M | $94.00M | -$57.00M | -$26.00M | -$69.00M |
| Investing cash flow | -$73.00M | -$87.00M | -$130.00M | -$188.00M | -$61.00M | -$90.00M | -$116.00M | -$185.00M | -$96.00M | -$74.00M | -$57.00M | -$135.00M |
| Financing cash flow | -$22.00M | $34.00M | -$20.00M | $116.00M | -$12.00M | $90.00M | $31.00M | $146.00M | -$20.00M | $40.00M | $12.00M | $86.00M |
| Stock-based compensation | $37.00M | $38.00M | $34.00M | $64.00M | $27.00M | $30.00M | $28.00M | $27.00M | $24.00M | $22.00M | $19.00M | $16.00M |
| Depreciation and amortization | $102.00M | $102.00M | $101.00M | $99.00M | $109.00M | $107.00M | $106.00M | $106.00M | $110.00M | $110.00M | $110.00M | $116.00M |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 7.3% | 9.1% | 9.4% | 9.8% | 7.1% | 5.1% | 3.5% | 9.1% | 18.8% | 17.5% | 18.0% | 17.8% |
| Operating margin | 11.3% | 6.0% | 2.7% | 8.0% | 7.4% | -0.9% | -7.3% | 6.8% | 3.6% | 2.1% | 0.5% | 4.2% |
| Net margin | 2.3% | -1.0% | -5.7% | -4.1% | -2.2% | -4.9% | -18.6% | -0.2% | 0.3% | -12.4% | -15.2% | -4.6% |
| Free cash flow margin | 12.9% | 5.9% | -5.5% | 4.3% | 4.9% | -4.2% | -11.9% | -5.5% | 7.9% | -4.7% | -2.4% | -5.9% |
| Current ratio | 1.56 | 1.55 | 1.53 | 1.55 | 1.51 | 1.55 | 1.56 | 1.60 | 1.57 | 1.65 | 1.70 | 1.74 |
| Debt to equity | 0.78 | 0.79 | 0.78 | 0.78 | 0.76 | 0.76 | 0.75 | 0.73 | 0.69 | 0.70 | 0.68 | 0.66 |
Source: XBRL data Bausch + Lomb Corporation files with the SEC, latest filing dated Oct 28, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| BLCO | $5.42B | +8.9% | -$111.00M | -2.0% | $7.15B |
| ALC | $10.40B | +4.9% | $980.00M | 9.4% | $37.45B |
| COO | $4.24B | +4.7% | $570.30M | 13.5% | $11.86B |
| WRBY | $934.66M | +9.9% | $7.47M | 0.8% | $3.15B |
| EYE | $2.03B | +7.8% | $50.29M | 2.5% | $1.41B |
| STAA | $328.27M | +42.4% | $530.0K | 0.2% | $1.27B |
| RXST | $121.83M | -14.3% | -$53.36M | -43.8% | $190.1M |
| LUCY | $3.41M | +72.5% | -$7.69M | -225.3% | $7.2M |